"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia

被引：0
作者：
Friedman, Daphne R. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源：
LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 03期
关键词：
DENDRITIC CELLS; GM-CSF; RITUXIMAB; MONOCYTES; THERAPY; CD52;
D O I：
10.3109/10428194.2012.727420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：441 / 442
页数：2
相关论文
共 11 条
[1]   Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies [J].
Albitar, M ;
Do, KA ;
Johnson, MM ;
Giles, FJ ;
Jilani, I ;
O'Brien, S ;
Cortes, J ;
Thomas, D ;
Rassenti, LZ ;
Kipps, TJ ;
Kantarjian, HM ;
Keating, M .
CANCER, 2004, 101 (05) :999-1008
[2]   Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine [J].
Beyer, M ;
Kochanek, M ;
Darabi, K ;
Popov, A ;
Jensen, M ;
Endl, E ;
Knolle, PA ;
Thomas, RK ;
von Bergwelt-Baildon, M ;
Bebey, S ;
Hallek, M ;
Schultze, JL .
BLOOD, 2005, 106 (06) :2018-2025
[3]   Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab [J].
Buggins, AGS ;
Mufti, GJ ;
Salisbury, J ;
Codd, J ;
Westwood, N ;
Arno, M ;
Fishlock, K ;
Pagliuca, A ;
Devereux, S .
BLOOD, 2002, 100 (05) :1715-1720
[4]   Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells [J].
Carlier, Jerome ;
Martin, Helene ;
Mariame, Bernard ;
Rauwel, Benjamin ;
Mengelle, Catherine ;
Weclawiak, Hugo ;
Coaquette, Alain ;
Vauchy, Charline ;
Rohrlich, Pierre ;
Kamar, Nassim ;
Rostaing, Lionel ;
Herbein, Georges ;
Davrinche, Christian .
BLOOD, 2011, 118 (26) :6783-6792
[5]   Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma:: Results of a phase II study [J].
Cartron, Guillaume ;
Zhao-Yang, Lu ;
Baudard, Marion ;
Kanouni, Tarik ;
Rouille, Valerie ;
Quittet, Philippe ;
Klein, Bernard ;
Rossi, Jean-Francois .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2725-2731
[6]   Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia [J].
Ferrajoli, Alessandra .
LEUKEMIA & LYMPHOMA, 2009, 50 (03) :514-516
[7]   Association of an increased frequency of CD14+HLA-DRlo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL) [J].
Gustafson, Michael P. ;
Abraham, Roshini S. ;
Lin, Yi ;
Wu, Wenting ;
Gastineau, Dennis A. ;
Zent, Clive S. ;
Dietz, Allan B. .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (05) :674-676
[8]   Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia [J].
Lin, TS ;
Flinn, IW ;
Lucas, MS ;
Porcu, P ;
Sickler, J ;
Moran, ME ;
Lucas, DM ;
Heerema, NA ;
Grever, MR ;
Byrd, JC .
LEUKEMIA, 2005, 19 (07) :1207-1210
[9]  
Orsini E, 2003, CANCER RES, V63, P4497
[10]   Early Treatment of High-Risk Chronic Lymphocytic Leukemia With Alemtuzumab and Rituximab [J].
Zent, Clive S. ;
Call, Timothy G. ;
Shanafelt, Tait D. ;
Tschumper, Renee C. ;
Jelinek, Diane F. ;
Bowen, Deborah A. ;
Secreto, Charla R. ;
LaPlant, Betsy R. ;
Kabat, Brian F. ;
Kay, Neil E. .
CANCER, 2008, 113 (08) :2110-2118
12